Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析

◆英語タイトル:Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15753
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Henry Schein Inc (HSIC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Henry Schein Inc (Henry Schein) is a provider of health care products and services to dental and medical practitioners. Its product portfolio consists of dental and medical products, software and technology and other value-added services. The company distributes both generic and branded drugs. Henry Schein supplies its products and provides services to dental practitioners and laboratories, physician practices, and government and other institutions through a centralized and automated distribution network. The company, along with its subsidiaries, operates in Germany, Canada, France, Switzerland, the UK and the US. It also manages affiliates in Iceland, Saudi Arabia and Turkey. Henry Schein is headquartered in New York, the US.

Henry Schein Inc Key Recent Developments

Mar 12,2019 Henry Schein to showcase comprehensive portfolio of solutions for Health Care Professionals at the 38th International Dental Show
Feb 26,2019 Henry Schein named one of the 2019 World’s most ethical companies by Ethisphere
Feb 21,2019 Zahn Dental Announces New Solutions, Live Educational Events, and Introduction of Zahn Digital Solutions at LMT Lab Day, February 21 – 23, in Chicago, IL
Feb 21,2019 Henry Schein One Unveils Entertaining Patient Theater Experience With New Booth At Chicago Midwinter Dental Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Henry Schein Inc – Key Facts
Henry Schein Inc – Key Employees
Henry Schein Inc – Key Employee Biographies
Henry Schein Inc – Major Products and Services
Henry Schein Inc – History
Henry Schein Inc – Company Statement
Henry Schein Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Henry Schein Inc – Business Description
Business Segment: Healthcare Distribution
Overview
Performance
Business Segment: Technology and Value Added Services
Overview
Performance
Geographical Segment: Other Countries
Performance
Overview
Geographical Segment: The US
Performance
Henry Schein Inc – Corporate Strategy
Henry Schein Inc – SWOT Analysis
SWOT Analysis – Overview
Henry Schein Inc – Strengths
Henry Schein Inc – Weaknesses
Henry Schein Inc – Opportunities
Henry Schein Inc – Threats
Henry Schein Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Henry Schein Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Henry Schein Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Henry Schein Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2019: Henry Schein to showcase comprehensive portfolio of solutions for Health Care Professionals at the 38th International Dental Show
Feb 26, 2019: Henry Schein named one of the 2019 World’s most ethical companies by Ethisphere
Feb 21, 2019: Zahn Dental Announces New Solutions, Live Educational Events, and Introduction of Zahn Digital Solutions at LMT Lab Day, February 21 – 23, in Chicago, IL
Feb 21, 2019: Henry Schein One Unveils Entertaining Patient Theater Experience With New Booth At Chicago Midwinter Dental Meeting
Feb 20, 2019: Henry Schein reports record fourth quarter and full year 2018 financial results
Jan 21, 2019: Save the Date: Henry Schein to Host the Dental Service Organization Education Forum, Featuring a Rich Lineup of Speakers and Courses
Jan 21, 2019: Save the Date Henry Schein to Host the Dental Service Organization Education Forum Featuring a Rich Lineup of Speakers and Courses
Jan 08, 2019: Henry Schein Announces Record Date, Distribution Date And Anticipated When-Issued Trading Market For Spin-Off Of Animal Health Business
Dec 17, 2018: CareCredit now integrated into Henry Schein’s Dental and Veterinary Practice Management Software Solutions
Dec 03, 2018: Henry Schein Disaster Relief Hotline is open to support customers affected by earthquake in Alaska
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Henry Schein Inc, Key Facts
Henry Schein Inc, Key Employees
Henry Schein Inc, Key Employee Biographies
Henry Schein Inc, Major Products and Services
Henry Schein Inc, History
Henry Schein Inc, Other Locations
Henry Schein Inc, Subsidiaries
Henry Schein Inc, Key Competitors
Henry Schein Inc, Ratios based on current share price
Henry Schein Inc, Annual Ratios
Henry Schein Inc, Annual Ratios (Cont...1)
Henry Schein Inc, Annual Ratios (Cont...2)
Henry Schein Inc, Interim Ratios
Henry Schein Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Henry Schein Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Henry Schein Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Henry Schein Inc, Performance Chart (2014 - 2018)
Henry Schein Inc, Ratio Charts
Henry Schein Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Henry Schein Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Takeuchi Mfg. Co Ltd:企業の戦略・SWOT・財務分析
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SANUWAVE Health Inc (SNWV):企業の財務・戦略的SWOT分析
    Summary Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company that develops and commercializes noninvasive biological response activating devices. The company's products portfolio include dermapace, which is used in the treatment of chronic and acute conditi …
  • Camber Energy Inc (CEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Camber Energy Inc (Camber Energy), formerly known as Lucas Energy, Inc., is an independent oil and gas company. It explores, develops, and produces crude oil, natural gas and natural gas liquids (NGL). The company has asset base in Texas and Oklahoma. Its producing fields include Lincoln, Lo …
  • Berry Global Group Inc:戦略・SWOT・企業財務分析
    Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report Summary Berry Global Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nemus Bioscience Inc (NMUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Nemus Bioscience Inc (Nemus Bioscience) is a life-science and biopharmaceutical company that offers discovering, developing and commercializing cannabinoid-based therapeutics. The company’s drug pipeline products include NB1111, NB1222, NB2111, NB2222 and Cannabinoid platform NB3111. Its can …
  • Viavi Solutions Inc:企業の戦略・SWOT・財務分析
    Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sterling Bank Plc
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Rigel Pharmaceuticals Inc (RIGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …
  • Black River Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Black River Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • SciBase AB (SCIB)-医療機器分野:企業M&A・提携分析
    Summary SciBase AB (SciBase) is a medical technology company that offers non-invasive detection and monitoring of skin tissue alterations. The company has developed point of care device for the accurate detection of malignant melanoma. It offers products which include electrical impedance spectrosco …
  • ViaCyte Inc-製薬・医療分野:企業M&A・提携分析
    Summary ViaCyte Inc (ViaCyte), formerly Novocell, Inc. is a regenerative medicine company that focuses on the development of cell replacement therapies for the treatment of diabetes. The company’s pipeline product portfolio includes VC-01, which is being developed as a therapy for T1D patients who h …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mincor Resources NL:企業の戦略・SWOT・財務情報
    Mincor Resources NL - Strategy, SWOT and Corporate Finance Report Summary Mincor Resources NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Libbey Inc (LBY):企業の財務・戦略的SWOT分析
    Libbey Inc (LBY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ames Construction Inc:企業の戦略的SWOT分析
    Ames Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas including cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neur …
  • Bellway Plc (BWY):企業の財務・戦略的SWOT分析
    Bellway Plc (BWY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Credit Du Nord Sa:企業の戦略・SWOT・財務分析
    Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report Summary Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Isovolta AG:企業の戦略的SWOT分析
    Isovolta AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Medherant Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆